Building Trust in Science with AminoChain ft. CEO Caspar Barnes
Listen Now
About This Episode
In this episode of DevNTell, Narb welcomes Caspar Barnes, the founder and CEO of AminoChain. Caspar details the mission of AminoChain to build a decentralized infrastructure for healthcare applications, aimed at democratizing access to bio-samples and scientific data. Initially starting as a marketplace for stem cell donations to address racial inequities in transplantation, the project has evolved into a comprehensive blockchain platform that connects bio-repositories. Caspar provides a live demo of their 'Specimen Center,' explaining how the platform manages regulatory compliance while enabling patient ownership and compensation for scientific contributions.
Key Takeaways
AminoChain began as a solution to racial disparities in stem cell matches by creating an NFT marketplace for donations.
The project evolved from a simple marketplace into a 'decentralized biobank' infrastructure intended to be the 'Ethereum of healthcare.'
Partnering with Syndicate allowed AminoChain to build an app-chain that handles HIPAA compliance and sensitive medical data by balancing on-chain trust with off-chain computation.
A major focus is currently on 'diseased tissue' repositories, aiming to unlock the 90% of bio-samples currently dormant in storage.
AminoChain’s roadmap includes a patient-facing portal where donors can track their samples and earn 'points' or incentives for their data's use in research.
Caspar emphasizes that DeSci (Decentralized Science) must prioritize innovation and progressive decentralization over 'crypto-first' narratives to succeed in institutional healthcare.
Featured Guest
Caspar Barnes
Founder & CEO @ AminoChain
Timestamps(click to jump)
Listen On
Resources & Links
Share This Episode
Share on XWatch Episodes Live!
Subscribe to our event calendar and never miss a live episode.
View Event Calendar